ADIPOQ and prostate cancer: Obesity leads to high circulating concentrations of insulin, leptin and insulin-like growth factor-I (IGF-I) and low levels of adiponectin, which have been described to promote prostate cancer growth and progression, thus increasing the risk of advanced prostate cancer [26].